← Eichor
Study identifier: NCT07680764 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Condition: Locally Advanced Non-Small Cell Lung Cancer (NSCLC) · Metastatic Non-Small Cell Lung Cancer (NSCLC)  ·  Sponsor: Bristol-Myers Squibb

PhasePhase 2
Planned participants160
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to assess the safety, tolerability, and efficacy of Imzokitug in combination with Pumitamig and Platinum-Doublet Chemotherapy (PDCT) versus Pumitamig and PDCT as first-line treatment for participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com  ·  855-907-3286  ·  Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (71)

Local Institution - 0170Athens, Georgia, United StatesNot Yet Recruiting
Local Institution - 0034Lexington, Kentucky, United StatesNot Yet Recruiting
Local Institution - 0171Lexington, Kentucky, United StatesNot Yet Recruiting
Local Institution - 0123Baltimore, Maryland, United StatesNot Yet Recruiting
Local Institution - 0180Hattiesburg, Mississippi, United StatesNot Yet Recruiting
Nebraska Cancer SpecialistsGrand Island, Nebraska, United StatesRecruiting
Oncology Hematology West PCOmaha, Nebraska, United StatesRecruiting
Local Institution - 0080New York, New York, United StatesNot Yet Recruiting
Local Institution - 0105Nashville, Tennessee, United StatesNot Yet Recruiting
Local Institution - 0095Houston, Texas, United StatesNot Yet Recruiting
Local Institution - 0135Madison, Wisconsin, United StatesNot Yet Recruiting
Local Institution - 0092Viedma, Río Negro Province, ArgentinaNot Yet Recruiting

+ 59 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07680764